This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress

September 8th, 2009

ESMO 34 will take place at the ICC Berlin - Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009.

There will be more than 2,000 presentations and over 15,000 participants from 120 countries, making it the largest European cancer congress to date.

The congress will discuss the latest advances in prevention, treatment and survivorship, proteomics, biomarkers, pharmacogenomics and imaging, as well as the latest evidence on epidemiological trends, complementary therapies and quality of life issues. For the first time, the meeting also features a patient advocacy track and a track on oncopolicy, which is aimed at strengthening European policy on cancer research and care.

There will be media news briefings at the following times:

Sunday 20 September, 16.00 hrs (CEST) in English (embargoed to Monday)

Monday 21 September, 11.00 hrs (CEST) in German

Tuesday 22 September, 11.15 hrs (CEST) in English

Wednesday 23 September, 11.15 hrs (CEST) in English

Here is a sample of the news results to be announced at the congress (embargoed to time of presentation at ECCO15-ESMO34):

  • Can aspirin prevent cancer in people with an inherited predisposition to colon cancer? International clinical trial has the answer.
  • Surgical removal of primary tumour improves survival in metastatic breast cancer patients.
  • Genetic identification of patients who are hypersensitive to radiotherapy helps improve treatment and avoid side-effects.
  • Potentially practice-changing results of phase III trial combining targeted heat therapy with chemotherapy in locally advanced soft tissue sarcoma.
  • Largest and most comprehensive study to date investigates links between prostate cancer hormone therapy and heart disease.
  • Largest study to date investigates the effect of whole-brain radiotherapy in patients with limited spread of primary cancer to the brain.
  • Meta-analysis clarifying the impact of adding cetuximab to various chemotherapy combinations in advanced non-small cell lung cancer.
  • Expert calls for new cancer research priorities and outlines strategy to cope with growing burden of cases.
  • Significant advances made in treatment of malignant melanoma: two trials show improvements in overall survival and rapid shrinking of tumours.
  • New results from SOLTI randomised trial on use of sorafenib in combination with chemotherapy in advanced breast cancer.
  • Could HPV vaccination and screening eradicate cervical cancer?
  • New figures on the numbers of new cancers in Europe caused by excess body fat.
  • Pancreatic cancer: researchers find drug that reverses resistance to chemotherapy.
  • New research on ultrasound shows it can predict tumour burden and survival in melanoma patients, sparing unnecessary surgery.
  • Innovative test for new cancer drugs will lead to quicker validation and safer and more efficient clinical trials.
  • Findings of the first study of teen experiences during the process of obtaining a cancer diagnosis.

ECCO (the European CanCer Organisation, which is organising the congress) and ESMO welcome the interest of the press in cancer issues and are happy to provide full assistance to journalists attending ECCO 15 - ESMO 34, or using the congress website as a resource in their coverage of cancer issues. A media centre with computing, fax, photocopying and free international phone and internet connections will be available.

Press Office at ECCO 15 - ESMO 34 opening times and telephone numbers:

Sunday 20 September 09.00 - 19.00 hrs (CEST)

Monday 21 - Wednesday 23 September 08.00 - 19.00 hrs

Thursday 24 September 08.00 - 15.00 hrs

Tel: +49 30 3038 1006 and +49 30 3038 1007

Fax: +49 30 3038 1024

Press officers: Emma Mason, Mary Rice, Emma Ross, Susanne Werner

Registration and hotel accommodation

ECCO 15 - ESMO 34 is open to bona fide representatives of print, electronic and broadcast media. For further details and media registration, visit the ECCO 15 - ESMO 34 section of the ECCO website at: www.ecco-org.eu

NB: Media registration in advance is strongly recommended, and hotel rooms will go very quickly so early booking via the ECCO website is recommended.

Source: ECCO-the European CanCer Organisation

Citation: Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress (2009, September 8) retrieved 23 August 2026 from https://sciencex.com/wire-news/13856441/media-registration-for-ecco-15-esmo-34-multidisciplinary-canc.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Back to list